To investigate the effect of NCAPD3 on prostate cancer development, we established stable NCAPD3-overexpression PC-3 cells (PC-3-Lv-NC3) and stable NCAPD3-knockdown 22Rv1 cells (22Rv1-Lv-shNC3). This evidence concerns the gene NCAPD3 and prostate carcinoma.